A5086721334- Diabetes Management and Research
- Diabetes and associated disorders
- Pancreatic function and diabetes
Helmholtz Zentrum München
2023-2024
Institute of Diabetes Research
2023
Abstract Context Staging and monitoring of presymptomatic type 1 diabetes includes the assessment for dysglycemia. Objective To assess ability continuous glucose (CGM) to differentiate between islet autoantibody-negative controls early-stage explore whether CGM classifiers predict progression clinical diabetes. Research Design Methods Children adolescents participating in public health screening autoantibodies Bavaria, Germany, were invited undergo with Dexcom G6. In total, 118 participated...
Fragestellung Steck et al. zeigten, dass CGM-Werte bei Time above (TA) >140 mg/dl von über 10% in Personen mit ≥ 1 Inselautoantikörper einer schnellen Progression zu einem Stadium 3 T1D assoziiert sind. In unserer Studie untersuchen wir, ob CGM-Messungen Kindern der Fr1da-Studie HbA1c, oraler Glukosetoleranztest (OGTT) und den jeweiligen Frühstadien 2 des korrelieren.